tiprankstipranks
Trending News
More News >
IBEX (IBEX)
NASDAQ:IBEX
US Market

IBEX (IBEX) AI Stock Analysis

Compare
172 Followers

Top Page

IB

IBEX

(NASDAQ:IBEX)

78Outperform
IBEX's strong financial performance and favorable earnings call insights are the primary drivers of its positive stock score. While technical indicators suggest potential overbought conditions, the company's attractive valuation and strategic initiatives position it well for future growth.
Positive Factors
Growth Strategy
IBEX's strong sales momentum is turning into accelerating growth.
Market Position
IBEX is seen as a market share gainer with a clean balance sheet, margin expansion, and inexpensive valuation.
Negative Factors
Automation Impact
IBEX has seen automation impacts over time and have grown well over time.
Industry Trends
Industry trends seem to be stabilizing, and margin trends have been good as revenue mix trending toward higher-margin services/geos.

IBEX (IBEX) vs. S&P 500 (SPY)

IBEX Business Overview & Revenue Model

Company DescriptionIBEX is a global provider of business process outsourcing (BPO) services, specializing in customer engagement, digital marketing, and technology solutions. The company operates across various sectors, including telecommunications, healthcare, retail, and financial services, offering a suite of services designed to enhance customer experience and operational efficiency for its clients.
How the Company Makes MoneyIBEX generates revenue primarily through its outsourcing services, where it partners with businesses to handle customer support, sales, and other back-office functions. The company earns money by entering into contracts with clients to provide tailored BPO solutions, charging fees based on service level agreements, transaction volumes, or a combination of both. Key revenue streams include customer service and support, technical support, and sales outsourcing. Significant factors contributing to IBEX's earnings include its global delivery model, which allows it to leverage cost efficiencies, and strategic partnerships with technology providers to enhance service offerings.

IBEX Financial Statement Overview

Summary
IBEX demonstrates strong profitability with impressive margins and a solid balance sheet. Despite minor concerns about revenue decline and negative free cash flow growth, overall financial health is strong, supporting operational sustainability and growth prospects.
Income Statement
82
Very Positive
IBEX has shown a strong performance in the TTM period with a Gross Profit Margin of 48.74% and a Net Profit Margin of 7.08%. The Revenue Growth Rate from the last annual report to TTM is 2.58%, indicating consistent growth. EBIT Margin stands at 8.66% and EBITDA Margin at 11.80%, showcasing solid profitability. A slight decline in revenue compared to the previous year is a minor concern but overall, the company demonstrates robust profitability supported by healthy margins.
Balance Sheet
76
Positive
The company maintains a Debt-to-Equity Ratio of 0.87, reflecting moderate leverage. Return on Equity (ROE) is 33.92%, indicating efficient use of equity to generate profits. The Equity Ratio is 39.97%, showing a stable financial position with a substantial equity base. Despite a decrease in total assets, the company's financial health remains sound with balanced leverage.
Cash Flow
79
Positive
Operating Cash Flow to Net Income Ratio is 1.02, pointing to good cash generation relative to income. Free Cash Flow to Net Income Ratio is 0.70, reflecting adequate free cash flow generation. Although the Free Cash Flow Growth Rate is negative at -4.24%, the company still generates sufficient cash flows to support its operations and investments. Overall, cash flow stability is solid with minor fluctuations.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
521.73M508.57M523.12M493.57M443.66M405.13M
Gross Profit
254.36M152.23M148.13M119.60M100.40M128.88M
EBIT
45.17M39.43M40.48M29.80M23.33M19.51M
EBITDA
67.49M60.96M73.96M52.80M51.53M47.17M
Net Income Common Stockholders
36.95M33.66M31.58M21.46M2.85M7.77M
Balance SheetCash, Cash Equivalents and Short-Term Investments
11.96M62.72M57.43M48.83M57.84M21.87M
Total Assets
156.28M293.90M293.32M290.14M274.29M195.24M
Total Debt
55.90M67.02M78.90M104.74M112.52M105.97M
Net Debt
43.94M4.30M21.47M55.91M54.67M84.10M
Total Liabilities
131.50M128.10M143.36M189.85M193.63M179.09M
Stockholders Equity
24.78M165.80M149.96M100.29M80.66M16.15M
Cash FlowFree Cash Flow
25.90M27.05M22.91M24.21M5.07M46.45M
Operating Cash Flow
37.76M35.90M41.86M50.13M25.90M51.72M
Investing Cash Flow
-11.86M-8.86M-19.04M-24.89M-20.17M-4.83M
Financing Cash Flow
-54.71M-21.73M-13.61M-33.28M30.43M-33.87M

IBEX Technical Analysis

Technical Analysis Sentiment
Negative
Last Price22.60
Price Trends
50DMA
24.65
Negative
100DMA
22.73
Negative
200DMA
20.18
Positive
Market Momentum
MACD
0.09
Positive
RSI
52.42
Neutral
STOCH
39.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IBEX, the sentiment is Negative. The current price of 22.6 is below the 20-day moving average (MA) of 24.68, below the 50-day MA of 24.65, and above the 200-day MA of 20.18, indicating a neutral trend. The MACD of 0.09 indicates Positive momentum. The RSI at 52.42 is Neutral, neither overbought nor oversold. The STOCH value of 39.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IBEX.

IBEX Risk Analysis

IBEX disclosed 49 risk factors in its most recent earnings report. IBEX reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

IBEX Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GG
80
Outperform
$8.27B16.5322.15%1.33%6.46%-16.94%
79
Outperform
$6.96B34.8521.80%12.74%9.92%
78
Outperform
$307.90M10.6427.88%1.65%35.92%
77
Outperform
$3.11B12.096.34%2.63%21.67%-17.91%
62
Neutral
$1.74B-2.21%14.44%84.58%
57
Neutral
$18.52B9.81-13.96%2.71%5.07%-23.65%
45
Neutral
$193.90M-75.62%14.29%-10.32%-3860.81%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IBEX
IBEX
22.50
8.08
56.03%
EXLS
Exlservice Holdings
41.85
10.90
35.22%
G
Genpact
46.79
14.92
46.82%
TTEC
TTEC Holdings
3.71
-5.70
-60.57%
FIVN
Five9
21.54
-40.26
-65.15%
CNXC
Concentrix
45.73
-14.64
-24.25%

IBEX Earnings Call Summary

Earnings Call Date: Feb 6, 2025 | % Change Since: 2.31% | Next Earnings Date: May 14, 2025
Earnings Call Sentiment Positive
The earnings call presented strong revenue growth and profitability improvements, driven by strategic client wins and AI solutions. Despite some challenges in specific verticals and increased capital expenditures, the company's overall trajectory is positive with continued investments in growth and diversification.
Highlights
Record Revenue and Growth
IBEX achieved its highest quarterly revenue in history at $140.7 million, up 6.1% from the previous year, marking the highest growth in two years.
Improved Profitability
Adjusted EBITDA margin expanded by 100 basis points to 11.8% from the prior year, with record Q2 adjusted net income of $9.6 million, up 20% from the prior year.
Strong EPS Performance
Adjusted EPS increased by 36% to $0.59 compared to the previous year.
Strategic Client Wins and AI Solutions
Closed five new logos in the quarter, including both traditional agent and generative AI deployments. Significant wins with WaveIX AI solutions for translation and automation.
Share Repurchase and Board Enhancements
Repurchased 3.6 million shares from TRGI, eliminating controlled company status under NASDAQ. Added three new members to the board with strong industry and AI expertise.
Lowlights
Decline in FinTech Revenue
FinTech vertical revenue declined by 15%, impacted by changes in client payment support models and geographic shifts.
Increased Capital Expenditures
Capital expenditures increased to $4.3 million or 3.1% of revenue, up from $2.9 million or 2.2% of revenue in the prior year quarter.
Net Cash Position Decrease
Net cash position decreased due to the share repurchase, moving from $60.8 million in net cash to $13.7 million in net debt.
Revenue Concentration in Largest Client
Largest client accounted for 12% of revenue, indicating some level of dependency on a single client.
Company Guidance
During the IBEX second quarter fiscal year 2025 earnings call, the company reported record Q2 revenue of $140.7 million, marking a 6.1% increase from the previous year. This growth was driven by significant expansions in key verticals such as health tech (31%), travel transportation and logistics (17%), and retail and e-commerce (4%), although offset by a 15% decline in FinTech. The adjusted EBITDA margin improved by 100 basis points to 11.8%, with adjusted net income rising 20% to $9.6 million and adjusted EPS increasing 36% to $0.59. The company highlighted strong offshore revenue growth of 14% year-over-year and a focus on high-margin omnichannel services. Additionally, IBEX's strategic initiatives, including new client wins and the WaveIX AI solutions, have reinforced its market position, leading to increased revenue retention and client diversification. The company also executed a $70 million strategic share repurchase, reducing its diluted share count and enhancing financial independence. Looking forward, IBEX raised its fiscal year revenue guidance to $525-$535 million and adjusted EBITDA to $68-$69 million, underlining confidence in continued growth and margin expansion.

IBEX Corporate Events

Private Placements and Financing
IBEX Completes $70 Million Share Purchase Transaction
Neutral
Jan 13, 2025

IBEX Limited has successfully completed a financial transaction involving the purchase of 3,562,341 common shares from The Resource Group International Limited for $70 million. The transaction was settled with $45 million in cash and a $25 million convertible promissory note, which was fully paid off using credit lines from HSBC, leading to the termination of the note.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.